Journal of Pediatric Neurology 2023; 21(06): 458-461
DOI: 10.1055/s-0043-1768246
Case Report

SARS-CoV-2-Related Pediatric Encephalopathy with Biphasic Convulsions and Cortical Blindness: A Case Report

Yuriko Shiraishi
1   Department of General Pediatrics, Okinawa Prefectural Nanbu Medical Center, Okinawa, Japan
,
1   Department of General Pediatrics, Okinawa Prefectural Nanbu Medical Center, Okinawa, Japan
,
Tsuyoshi Matsuoka
2   Division of Child Neurology and Child Psychiatry, Okinawa Prefectural Nanbu Medical Center, Okinawa, Japan
,
Masaya Numazawa
1   Department of General Pediatrics, Okinawa Prefectural Nanbu Medical Center, Okinawa, Japan
,
Takashi Matsuoka
1   Department of General Pediatrics, Okinawa Prefectural Nanbu Medical Center, Okinawa, Japan
› Author Affiliations
Preview

Abstract

Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) is an encephalopathy syndrome that develops during the febrile phase of infection and is characterized by biphasic seizures and bright tree appearance (BTA) on imaging. In this study, we examined a 1-year-old child who was diagnosed with AESD caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. He had a fever for 2 days and was diagnosed with coronavirus disease 2019 on the day of consultation based on a positive antigen test for SARS-CoV-2. The seizures had stopped on arrival to hospital; however, symptoms of encephalopathy persisted. Despite being treated for acute encephalopathy with steroid pulse therapy, vitamins, and remdesivir, he had poor expressive language, and electroencephalography showed generalized slow waves. A repeat head magnetic resonance imaging showed BTA in the parietal and occipital lobes, and seizures recurred during hospital stay. He was also found to have cortical blindness. At the 4-month follow-up, the vision gradually improved and the hand movements recovered. SARS-CoV-2 infection can cause febrile convulsions, which can lead to the development of AESD. Furthermore, a subtype of AESD has occipital lobe predominant lesions that can cause visual impairment.

Ethics Approval and Consent to Participate

Informed consent was obtained from the patient's parents for the publication of this report. The Independent Ethics Committee approved this study (R4–156).




Publication History

Received: 29 January 2023

Accepted: 20 March 2023

Article published online:
13 April 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany